Search Results - "Passaretti, S"

A parsimonious model for springs discharge reconstruction and forecast for drought management: Lessons from a case study in Central Italy by Guyennon, N., Passaretti, S., Mineo, C., Boscariol, E., Petrangeli, A.B., Varriale, A., Romano, E.

“…Karst springs located in Central Apennine ridge (Central Italy), in the Tiber River basin. The assessment of water availability is a key issue in a water…”
Get full text

Correlation between oropharyngeal pH‐monitoring and esophageal pH‐impedance monitoring in patients with suspected GERD‐related extra‐esophageal symptoms by Mazzoleni, G., Vailati, C., Lisma, D. G., Testoni, P. A., Passaretti, S.

“…Background 24‐hour esophageal pH‐impedance (pH‐MII) is not totally reliable for laryngopharyngeal reflux (LPR). Oropharyngeal (OP) pH‐monitoring with the Dx‐pH…”
Get full text

OC.04.3: Transoral Anterior Fundoplication (TAF) with Medigus Ultrasound Surgical Endostapler (MUSE™) for the Treatment of Gastroesophageal Reflux Disease (GERD): 6-Month Results from a Single-Center Prospective Study by Testoni, P.A, Testoni, S.G.G, Mazzoleni, G, Fanti, L, Passaretti, S

Get full text

Reflux oesophagitis in Italy (Diomede project) by Baldi, F, Cavoli, C, Solimando, R, Bianco, M.A, Cipolletta, L, Costamagna, G, Passaretti, S

“…Abstract Aims A multicentric observational study was performed to update the available information on reflux oesophagitis in Italy. Methods In phase I, the…”
Get full text

A new medical device to assist the introduction of ambulatory 24-h pH-metry probe by Mangiavillano, B., Mezzi, G., Strini, G., Testoni, P.A., Passaretti, S.

Get full text

OC.08.1: MEAN BASAL ESOPHAGOGASTRIC JUNCTION PRESSURE IS A BETTER PREDICTOR OF CONCLUSIVE GASTROESOPHAGEAL REFLUX DISEASE THAN ESOPHAGOGASTRIC JUNCTION CONTRACTILE INTEGRAL DIFFERENTIATING REFLUX PHENOTYPES by Vespa, E., Passaretti, S., Fanizza, J., Fasulo, E., Bara, R., Fratto, M.C., Barchi, A., Danese, S.

Get full text

T.09.9: ON THERAPY PH-IMPEDANCE TESTING IN ASYMPTOMATIC BARRETT'S ESOPHAGUS PATIENTS CLARIFIES ESOPHAGEAL ACID EXPOSURE POTENTIALLY GUIDING ANTI-REFLUX THERAPY by Vespa, E., Fasulo, E., Viale, E., Fanizza, J., Barchi, A., Fratto, M.C., Passaretti, S., Danese, S.

Get full text

Standards for oesophageal manometry. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente (GISMAD) by Passaretti, S, Zaninotto, G, Di Martino, N, Leo, P, Costantini, M, Baldi, F

“…Manometry is an important tool in the diagnosis of oesophageal motility, disorders, but proper instruments and methods are needed to obtain useful clinical…”
Get more information

T.01.5 PRIMARY AND SECONDARY POSITION IN HIGH RESOLUTION ESOPHAGEAL MANOMETRY: IS THERE A DIFFERENCE? by Vaiano, M.L., Notaristefano, C., Ogliari, C., Passaretti, S., Bona, D., Ardizzone, S., Dell’Era, A.

Get full text

OC.18.11: LONG-TERM OUTCOMES OF MAINTENANCE THERAPY IN ADULT AND PEDIATRIC EOSINOPHILIC ESOPHAGITIS: A SYSTEMATIC REVIEW AND METANALYSIS by Barchi, A., Mandarino, F.V., Dell'Anna, G., Fasulo, E., Yacoub, M., Albarello, L., Massimino, L., Ungaro, F., Savarino, E.V., Passaretti, S., Danese, S., Vespa, E.

Get full text

T.01.4: PATIENTS WITH NONEROSIVE HEARTBURN AND EPIGATRIC PAIN SYNDROME (EPS) ARE NOT CLINICALLY DISTINGUISHABLE AND BENEFIT OF THE SAME TREATMENT. A RANDOMIZED CONTROLLED TRIAL (RCT) POST HOC ANALYSIS by Corazziari, E.S., Gasbarrini, A., D'Alba, L., D'Ovidio, V., Riggio, O., Passaretti, S., Annibale, B., Cicala, M., Repici, A., Bassotti, G., Ciacci, C., Di Sabatino, A., Neri, M., Bragazzi, M.C., Ribichini, E., Radocchia, G., Iovino, P., Marazzato, M., Schippa, S., Badiali, D.

Get full text

OC.15.5: POLIPROTECT IS AN EFFECTIVE TREATMENT TO MANAGE PPI DEPRESCRIBING. A RANDOMIZED CONTROLLED TRIAL (RCT) POST HOC ANALYSIS by Corazziari, E.S., Gasbarrini, A., D'Alba, L., D'Ovidio, V., Riggio, O., Passaretti, S., Annibale, B., Cicala, M., Repici, A., Bassotti, G., Ciacci, C., Di Sabatino, A., Neri, M., Bragazzi, M.C., Ribichini, E., Radocchia, G., Iovino, P., Marazzato, M., Schippa, S., Badiali, D.

Get full text

T.01.9 TRANSORAL INCISIONLESS FUNDOPLICATION FOR GASTROESOPHAGEAL REFLUX DISEASE INDUCES ESOPHAGEAL MUCOSAL HEALING UP TO TWO YEARS AFTER THE INTERVENTION AS DOCUMENTED BY THE MEAN NOCTURNAL BASELINE IMPEDANCE by Barchi, A., Testoni, S.G.G., Passaretti, S., Leuzzi, F., Ribichini, E., Notaristefano, C., Giollo, P., Parise, C., Azzolini, F., Fanti, L., Testoni, P.A., Danese, S.

Get full text

T01.02.12 THE DIAGNOSTIC USEFULNESS OF E-CADHERIN AND EPIDERMAL GROWTH FACTOR (EGF) IN SYMPTOMATIC GASTRO-ESOPHAGEAL REFLUX DISEASE by Ciavarella, L., Sanvito, E., Antonelli, M., Ribichini, E., Belloni, C., Daverio, R., Locatelli, M., Testoni, P.A., Passaretti, S.

Get full text

T.01.11 AN RC TRIAL COMPARING THE MUCOSAL PROTECTIVE AGENT (MPA) POLIPROTECT (NEOBIANACID®) (P) AND OMEPRAZOLE (O) IN THE TREATMENT OF HEARTBURN AND EPIGASTRIC PAIN/BURNING IN NON-EROSIVE REFLUX DISEASE (NERD) AND EPIGASTRIC PAIN SYNDROME (EPS) by Corazziari, E.S., Gasbarrini, A., D'Alba, L., D'Ovidio, V., Riggio, O., Passaretti, S., Annibale, B., Cicala, M., Repici, A., Bassotti, G., Ciacci, C., Di Sabatino, A., Neri, M., Bragazzi, M., Ribichini, E., Radocchia, G., Marazzato, M., Schippa, S., Badiali, D.

Get full text

P.05.17 ULTRASOUND-GUIDED TRANSORAL FUNDOPLICATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE: RESULTS UP TO 24 MONTHS FROM A SINGLE-CENTER PROSPECTIVE STUDY by Testoni, P.A., Mazzoleni, G., Distefano, G., Testoni, S.G.G., Antonelli, M., Fanti, L., Passaretti, S.

Get full text

Long-term Follow-up and Serologic Assessment After Triple Therapy with Omeprazole or Lansoprazole of Helicobacter-associated Duodenal Ulcer by Fanti, Lorella, Ieri, Rossella, Mezzi, Gianni, Testoni, Pier Alberto, Passaretti, Sandro, Guslandi, Mario

“…We assessed both the effectiveness of two Helicobacter pylori (Hp) eradication triple therapies and the usefulness of serology in the follow-up. Fifty patients…”
Get full text

P.01.5 TRANSORAL INCISIONLESS FUNDOPLICATION WITH ESOPHYX (TIF 2.0) FOR GASTRO-ESOPHAGEAL REFLUX DISEASE: THREE- TO TEN-YEAR OUTCOMES IN A PROSPECTIVE OBSERVATIONAL SINGLE-CENTER STUDY by Testoni, P.A., Distefano, G., Mazzoleni, G., Testoni, S.G.G., Fanti, L., Antonelli, M., Passaretti, S.

Get full text

P.01.14 TRANSORAL ANTERIOR FUNDOPLICATION (TAF) WITH MEDIGUS ULTRASOUND SURGICAL ENDOSTAPLER (MUSE) FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD): 12-MONTHS RESULTS FROM A SINGLE-CENTER PROSPECTIVE STUDY by Testoni, P.A., Mazzoleni, G., Distefano, G., Testoni, S.G.G., Fanti, L., Antonelli, M., Passaretti, S.

Get full text

OC.07.2 COMPARISON BETWEEN ESOPHYX AND MUSE SYSTEMS FOR TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD): 6 AND 12-MONTH RESULTS FROM A SINGLE-CENTER RETROSPECTIVE STUDY by Testoni, P.A., Mazzoleni, G., Distefano, G., Testoni, S.G.G., Fanti, L., Antonelli, M., Passaretti, S.

Get full text